Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
NCT ID: NCT07182981
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2025-08-04
2027-08-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
NCT07183072
Mouth Handicap in Systemic Sclerosis
NCT04273386
Exercise With Scleroderma Functional Outcomes
NCT06425653
Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis
NCT06598982
Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis
NCT02105818
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases diagnosed with scleroderma
Child and adult scleroderma patients who visited the rheumatology outpatient clinic at a university hospital will complete a questionnaire.
Questionnaire application for child and adult scleroderma patients
Scales will be applied to cases diagnosed with scleroderma
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire application for child and adult scleroderma patients
Scales will be applied to cases diagnosed with scleroderma
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cases aged 7-18 years will be included.
* Individuals diagnosed with scleroderma,
* Individuals over the age of 18 will be included.
Exclusion Criteria
* Cases that are not willing to participate in the study will be excluded.
* Having participated in a regular exercise program for the past 3 months
* Individuals who are not willing to participate in the study
For adults diagnosed with scleroderma:
* Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
* Individuals who are not willing to participate in the study will be excluded.
* Having participated in a regular exercise program for the past 3 months
* Individuals who are not willing to participate in the study
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Orkun Tüfekçi
Principal Investigator, PT, PhD(c)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Çankaya, Ankara, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBA 25/528
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.